GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPd3Z3UjlLZ1p1dURRZVBEZHZYbG1pNUtfUFRYM2NGeW1RWkFoUndGYmVveUJHd2FZeDQzYWtXbjR2d1FRZ25KcjQzeFFQcVp5TFo3VmNJcUFLRjR4Uk9LekpPanZHZUhRX24wLUVMS3hLREN0bmozdnFNNGI2VmZSMTd5dm5nSGl4S2hya2I0c29aWDJsVlVWeFM1cnZhZ1hDNjJwQUFJeDRDc0x3RGotczlOTHk1WGdjVWYxam90RE95bXUzdEU3WjlpTkxHOVJIWDRsMw?oc=5" target="_blank">GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMMerck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026 at 02:52 PMViking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters
Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge Reuters
September 22, 2026 at 08:10 PMKimberly-Clark offers remedies in bid for EU approval of Kenvue deal - reuters.com
Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal reuters.com
September 23, 2026 at 04:22 PMWegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com
September 21, 2026 at 05:02 AM